News

BioNTech (BNTX) recently witnessed a 13.9% increase in its share price over the last quarter. This period saw significant executive changes, including the upcoming departure of Chief Strategy ...
BioNTech SE (NASDAQ: BNTX) is one of the 13 Best German Stocks to Invest in Now. It is a clinical-stage biotechnology company focused on immunotherapies to treat cancer and other serious diseases.
Review the current BioNTech SE ADR (BNTX:XNAS) dividend yield and history to decide if BNTX is the best investment for you.
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
An announcement from BioNTech SE ( (BNTX)) is now available. On July 17, 2025, BioNTech SE announced that Ryan Richardson will step down as Chief Strategy Officer on September 30, 2025, to pursue ...
Last month, Bristol Myers Squibb BMY announced a strategic collaboration agreement with BioNTech BNTX for the global co-development and co-commercialization of the latter’s investigational ...
Read about BioNTech SE ADR (BNTX:XNAS) stock and today's latest news and financial updates.
Get the latest BioNTech SE (BNTX) stock news and headlines to help you in your trading and investing decisions.
Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Find annual and quearterly earnings data for BioNTech SE American Depositary Share (BNTX) including earnings per share, earnings forecasts at Nasdaq.com.